Previous Article in Journal
Synthesis of 2-Azetidinones via Cycloaddition Approaches: An Update
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

C2-Symmetric Amino Acid Amide-Derived Organocatalysts †

1
Department of Chemistry, College of Science, Al-Nahrain University, Jadriya, Baghdad 64021, Iraq
2
UK National Crystallography Service, Chemistry, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK
3
Department of Chemistry, Durham University, South Road, Durham DH1 3LE, UK
4
School of Natural Sciences (Chemistry), Bangor University, Bangor LL57 2UW, UK
5
School of Life Sciences, The University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK
6
Centre for Environmental Biotechnology, Bangor University, Deiniol Rd, Bangor LL57 2UW, UK
*
Author to whom correspondence should be addressed.
Dedicated to the staff and students of the Department of Chemistry, University College of North Wales, 18 October 1884–31 July 2022.
Reactions 2024, 5(3), 567-586; https://doi.org/10.3390/reactions5030027 (registering DOI)
Submission received: 6 June 2024 / Revised: 31 July 2024 / Accepted: 16 August 2024 / Published: 24 August 2024

Abstract

:
N-alkylated C2-symmetric amino acid amide derivatives were shown to catalyse the Michael addition of 2-hydroxy-1,4-napthoquinone to β-nitrostyrene, achieving a maximum ee of 44%. The corresponding trifluoroacetic acid salts also catalysed the aldol reaction between 4-nitrobenzaldehyde and hydroxyacetone, leading to the formation of predominantly syn-aldol products in up to 55% ee. Aspects of the solvent dependence of the aldol reaction and the H-bonding of the catalyst were investigated.

1. Introduction

Organocatalysis of organic reactions continues to be of significant interest, particularly the design and application of novel catalysts to asymmetric C–C bond formation [1,2,3,4,5,6,7,8,9,10]. We recently reported [11,12] the preparation of a range of amino acid-derived guanidines which were shown to have some potential as asymmetric organocatalysts in the Michael reaction. It was, however, apparent that several problems were associated with this work. Our initial L-proline-derived catalysts (for example 4) gave, at best, a modest 56% ee for the formation of the Michael adduct 3 from the addition of 2-hydroxy-1,4-napthoquinone 1 to β-nitrostyrene 2. These catalysts were found to be difficult to prepare as the intermediates in their synthesis were prone to racemization. We also investigated several N-protected C2-symmetric amino acid-derived catalysts including 5 (18–22% ee over three solvents) and 6 (15–26% ee over two solvents). These were not as successful as catalyst 4 and gave very slow rates of conversion due to low basicity (Scheme 1).
We were able to deduce from crystallographic studies that these catalysts took part in strong intramolecular H-bonding, which may be preventing the desired intermolecular interaction of catalyst with substrate. Our overall goal in this research was to develop a catalyst that takes part in strong associative interactions with the reactants. The various modifications made to our catalyst structures did not lead to any improvement in ee, and it was apparent from X-ray studies that the H-bonding patterns observed are not predictable. This suggested that the ability of the guanidine to form multiple strong H-bonds is not a favorable one and our original goal [11,12] to employ a simplified range of base catalysts might be more advantageous [13,14,15]. This proposition was supported by an investigation in the solid state demonstrating extensive intra- and intermolecular H-bonding abilities of the proline, guanidine, and/or amide functional groups within these organic moieties. Based on these observations, we have investigated the simpler N,N-dimethylated C2-symmetric amides of general structure 7 (Figure 1), which should have less capability for strong intramolecular H-bonding.

2. Preparation of Michael Catalysts

The catalysts 7a–e were prepared by reaction of the required diamine 8a–e with a 2-fold excess of N,N-dimethylphenylalanine [16], which had been activated by treatment with CDI in DMF (Method A). This gave the required catalysts but in consistently low yield (21–33% over 5 examples), and unfortunately, the catalysts were consistently contaminated with unidentified by-products and required repetitive chromatography to achieve high purity. An alternative method (Method B) was attempted for compound 7f, which reversed the coupling and methylation steps. Thus, the diamine 8f (n = 5) was coupled with a 2-fold excess of Z-l-Phe-OH activated using CDI, following which the intermediate bis-Cbz-protected amine was simultaneously deprotected and methylated in situ using Pd/C in the presence of methanolic formaldehyde solution. This gave 7f in an excellent 76% yield, and the method was next applied to the most successful (vide infra) catalysts 7a and 7b. Unfortunately, the method was not applicable to these compounds as they were insoluble in most of the solvents we employed. Even on prolonged reaction times (7–10 days), the deprotection was slow at 1 atm of hydrogen, and low yields were obtained. Despite this, after simple chromatography, the compounds were obtained in high purity. In order to improve this process for catalyst 7c, the corresponding bis-Cbz-protected amine was deprotected using HBr/AcOH, and the diamine formed methylated in situ using Pd/C in the presence of methanolic formaldehyde solution (Method C). This gave catalyst 7c in 80% yield (4.0 g scale) after a simple work-up (Entry 2(c), Table 1). We also attempted to prepare the dimethyl-substituted base 10 from Cbz-l-Phe-OH by Method B and had some measure of success (Entry 7(b), Table 1), obtaining a 63% yield. However, the reaction was capricious, and repetition of the hydrogenation step led to varied results. We repeated the reaction using hydrogenation in the presence of formaldehyde over Raney Ni and obtained a better result and found purification was easier, leading to 10 in 73% yield from the intermediate diamine (Method D, entry 7(d)). This method was utilized for the proline-derived catalysts 11a, 11b, and 12, giving them in 65%, 59%, and 38% yield from the intermediate diamines (Scheme 2, Table 1).

3. Michael Reaction—Catalytic Studies

We initially investigated our previously studied reaction [11,12] of 2-hydroxy-1,4-napthoquinone 1 to β-nitrostyrene 2 leading to the Michael product 3 (Scheme 3, Table 2).
The catalysts 7a–f were all successful in this reaction, with the catalysts 7b and 7d both giving 44% ee (Table 2, entries 1–6); however, there was no clear relationship between the proximity of the amides and any improvement in ee. We next tried the dimethyl-substituted catalyst 10, hoping for an improvement [17]; however, there was no appreciable increase in ee (Table 2, entry 7). The reactions involving the three proline-derived catalysts (Table 2, entries 8–11) gave very poor ees (9–15%) in comparison to the previous catalysts. Interestingly, compound 11a gave poor conversion over the standard reaction time (Table 2, entry 8) and required 14 days to achieve comparable yields to the other catalysts (Table 2, entry 9). Additionally, despite numerous efforts to obtain suitable crystals of all the catalysts employed, catalyst 11a was the only compound that gave crystals suitable for X-ray analysis, which were obtained on standing from a dichloromethane solution and were found to crystallise in the orthorhombic P21212 space group (see Table 3 for crystallographic details). There was disorder of the entire bridging diamide units, which was best modelled over two sites (split in 65:35 occupancy). Intramolecular hydrogen bonding is observed between the proline N atoms (N2 and s.e.) and nearby amide NH functional groups at distances of 2.39(4) Å (N1(H1)⋯N2) and 2.47(7) Å (N1B(H1BA)⋯N2; Figure 1). Intermolecular H-bonding is also found between the carbonyl O atoms (O1 and O1B and s.e.) and neighbouring diamide nitrogen protons (H1′ and H1BA′; where ′ = x, y, 1 + z) at distances of 2.06(4) Å (O1⋯N1′(H1); Figure 1) and 2.06(6) Å (O1BN1B′(H1BA′)). These intermolecular interactions allow the superimposable alignment of the individual units of 11a along the c unit cell direction (Figure 2 and Figure 3). The 1D hydrogen-bonded rows pack efficiently in three dimensions using the common brickwork motif.
Two points of note from the X-ray structure of 11a are, firstly, the disorder present in the -CH2CH2- linker. It is likely this disorder will be present in the longer chain analogue, and this might explain the lower ees achieved by these catalysts. Secondly, the intramolecular H-bonds between N1(H1)⋯N2 of 2.39(4) Å represent a relatively strong interaction and might be expected to be preserved in solution [18,19]. If reactions involving these catalysts are determined by the breaking of this bond, then this might be a significant factor in determining ee and the relatively slow progress of the reaction.
Following this work, we investigated the reaction of β-nitrostyrene 2 with dimethyl malonate using the catalysts 7b and 7f and found that the catalysts were ineffective in this reaction. Both 7b and 7f were able to catalyse the Michael addition of acetylacetone and 1,3-diphenylpropane-1,3-dione to β-nitrostyrene 2; however, the ees for this process were low (15% and 11%, respectively); full details are given in the supplementary information.

4. Conclusions on Michael Additions

We can conclude from these reactions that the dimethylamine/amide-linked catalysts are catalysts for this process, but the ees obtained are only modest and do not achieve levels of asymmetric induction achieved by other catalysts [1,2]. There is possibly a strong intramolecular H-bond, based on previous studies on guanidine-based catalysts, which might need to be broken to allow the reaction to proceed with efficiency [11,12,20]. The shorter chain length catalysts (7a to 7d) appear to give better results. With the catalyst precursors in hand, we next went on to study an aldol-type reaction.

5. Aldol Reactions

We were interested in other potential applications of these catalysts and were intrigued by the work of Zhao and co-workers [21] and the more recent work of Jimeno [22], who reported that the catalysts 13 and 14 catalysed the biomimetic aldol reaction [23,24] between aldehyde 15 and hydroxyacetone 16, leading to the formation of syn-17 and anti-17. Interestingly, the free amine catalyst 13 leads to predominantly anti-17, whilst the salt 14 leads to the syn-17 product. (Scheme 4)

6. Preparation of Aldol Catalysts

The required diamine trifluoroacetate catalysts 19a–f, 21 and 23a,b were prepared from the diamines 8a–f and 9 via the Boc-protected intermediates 18a–f [25,26,27], 20 and 22a,b, [28,29] by treatment with trifluoroacetic acid in chloroform, followed by drying under vacuum for 24 h (Scheme 5).

7. Aldol Reaction—Catalytic Studies

The initial study was the reaction between 15 and 16 (Scheme 4) and employed catalysts 19a–f and 21 and intended to study the relationship between the de (syn- to anti-ratio), ee, and the chain length within the catalysts. A standard set of conditions was employed in the initial reactions, and the results are shown in Table 4 (entries 1–7). It was apparent from these results that all 7 catalysts studied gave very similar syn- to anti- ratios, with the syn-17 product as the major diastereoisomer (Table 4, entries 1–7). It was found that the shortest chain length catalyst 19a gave the best levels of conversion and the highest ee, with a 50% ee for syn-17 and a 72% ee for the anti-17 product (entry 1). The ee decreases as the chain length increases, becoming fairly constant at a chain length of 4 or more carbons (Table 4, entries 3–6). The most successful catalysts, 19a, 19b, and 21, were investigated further by increasing the concentration of the reaction and reaction time (Table 4, entries 8–10). This led to an increased conversion; however, the syn:anti selectivity was lower in all cases, as were the ees. We also investigated the effect of increasing the number of equivalents of hydroxyacetone 16 (Table 4, entries 11–13) at the higher reaction concentration. This gave increased conversion (72–86% over the three reactions). In the case of 19a and 19b (Table 4, entries 11 and 12), the syn:anti ratio was much poorer than in the previous examples (Table 4, entries 1 and 2); however, for catalyst 21, this effect was less so (Table 4, entry 13 versus entry 10). The problem associated with increasing the relative amount of hydroxyacetone 16 might stem from the reagent acting as a protic solvent, and we next ran a series of experiments with catalysts 19a, 19b and 21 with 16 as the solvent (Table 4, entries 14–16). As expected, this led to a similar loss of syn:anti selectivity in all cases and much lower ees. This suggests that the protic nature of 16 may be an issue in these reactions. Finally, the proline-derived catalysts 23a and 23b were attempted (Table 4, entries 17, 18). These catalysts gave reasonable conversion but no appreciable syn:anti selectivity and mediocre ee, which was the opposite of that seen for the other catalysts. (similar reversals of selectivity have been reported [22,30] for proline-derived catalysts).
We next investigated the effect of varying solvent in the reaction (Table 5) and found that under the standard conditions, the best conversions were observed in THF (75%, Table 5, entry 1), ethanol (73%, Table 5, entry 2), acetonitrile (44%, Table 5, entry 3), and propan-2-ol (44%, Table 5, entry 4). It was observed, however, that the syn:anti selectivity of these systems was lower and slightly in favour of the anti-17 product, but the ees of both the syn-17 and anti-17 were of the same magnitude as that observed in DMF (Table 5, entry 0; repeated for convenience). Other solvents gave considerably poorer conversion over 48 h particularly the protic solvents methanol, ethylene glycol, and water (Table 5, entries 6, 8, and 9); however, methanol did give good syn-anti selectivity over 18% conversion).
Based on these experiments, we investigated the use of increased catalyst amount (0.2 equiv.) over a longer time period (96 h) in the best predicted solvents (Table 6). In all 4 reactions using 0.2 equivalents of catalyst, the conversion was considerably improved, with over 92–99% conversion for DMF, THF, and EtOH (Table 6, entries 1–3). The syn:anti selectivity was best in the case of DMF (Table 6, entry 1) and was poorer in the case of THF, EtOH, and MeOH (Table 6, entries 2–4). The ees for the anti-17 product remained high at 75–86%, with the ees of the syn-17 fairly consistent at 46–55% ee.
The diastereoselectivity of these reactions is low; however, in some cases, the ees are reasonable. In order to progress the work, we looked at the work of Jimeno, who reported [22] the use of the threonine acyl guanidine catalyst 14 (Scheme 4), which was reported to be a superior catalyst in this reaction in comparison to other amino acid acyl catalysts. It was suggested that a stabilizing hydrogen bonding network amongst the acylguanidinium moiety, the enamine nitrogen, and the aldehyde carbonyl oxygen was an important feature of this catalyst. We thus theorized that the incorporation of a threonine into our catalysts might improve selectivity. We attempted to prepare catalyst 25 via our standard coupling method using N-Boc-l-threonine 24, activation using CDI in dichloromethane, and coupling with ethylene diamine 8a (n = 0). This method, however, led to the formation of a complex product, possibly polymeric in nature. We tried the alternate coupling method reported by Jimeno [22] using EDC.HCl and HOBt, which gave the protected intermediate 25 in 69% yield. This was smoothly deprotected to give 26 using TFA in chloroform (Scheme 6). We applied this catalyst to the aldol reaction and found that over the standard conditions (0.2 equivalents, 4 days), there was an increase in syn:anti selectivity (entry 1); however, the conversion was low, as was the ee of both syn-17 and anti-17. We repeated the reaction at a lower temperature for 8 days (entry 2), and this gave a similar conversion and again poor ees. Reverting to room temperature and allowing the reaction to run for 10 days (Table 7, entry 3) gave a 71% conversion but only 22% ee for the syn-17 product and 14% ee for anti-17.
These results might indicate that any potential H-bonding interactions to the amino acid portion of catalyst 26 appear to be detrimental to the reaction. Indeed, the proximity of the two hydroxyl groups in catalyst 26 to any intermediates in the reaction might have a similar disruptive effect on conversion to that observed in the reactions performed in water, methanol, and ethylene glycol. The reaction, in agreement with the work of Jimeno [22], does show predominantly syn-selectivity (Table 7).

8. Conclusions on Aldol Reactions

From the aldol reactions investigated, we can conclude that catalyst 19a appears to be the best of our catalysts for this process, leading to a slight bias for the syn-17 product in acceptable ee. In most cases using 19a–f, the l-phenylalanine-derived catalysts, the ees observed were always greater for the anti-17 product. The use of l-proline-derived catalysts had a detrimental effect on selectivity and inverted the enantioselectivity, as observed by others [22,30]. The use of an l-threonine-derived catalyst capable of H-bonding interactions had a detrimental effect on enantioselectivity. Jimeno [11] put forward a transition state 27 (from modelling studies) for his catalyst 14, in which the aldehyde undergoes H-bonding interactions with the guanidinium portion of the enamine intermediate. This explains the syn-selectivity observed; however, no role for the hydroxyl group on the threonine residue was put forward. Barbas et al. [31] put forward a similar transition state 28 for the identical aldol reaction catalysed by l-threonine and tBuO-l-threonine. In these cases, the carboxylic acid of the amino acid is involved in H-bonding to the aldehyde, and there appears to be little difference in the syn-anti selectivity between the l-threonine and tBuO-l-threonine catalysts (Figure 4).
Based on these observations and the poor selectivity observed with the l-threonine-derived catalyst 26, we might speculate that a similar transition state is in operation. However, one complicating factor might be that the catalysts themselves might be present as dienamines in which both amine groups have reacted with the excess of hydroxyacetone. We hope to report further studies on similar catalysts in the future.

9. General Procedures

Unless otherwise noted, reactions were stirred and monitored by TLC. TLC plates were visualized using iodine, phosphomolybdic acid, or under UV light. All anhydrous reactions were conducted under a static argon atmosphere using oven-dried glassware that had previously been cooled under a constant stream of nitrogen. Reagents, dry solvents, and starting materials were purchased from commercial suppliers and used without further purification. Flash column chromatography was performed on Davisil® silica gel (35–70 microns) with the eluent specified in each case; TLC was conducted on precoated E. Merck silica gel 60 F254 glass plates. Unless specified, 1H and 13C NMR spectra were recorded on a Bruker Avance 400 spectrometer (Bruker (UK) Ltd. Coventry, UK) with an internal deuterium lock at ambient temperature at 400/100 MHz with internal references of δH 7.26 and δC 77.16 ppm for CDCl3, δH 3.31 and δC 49.00 ppm for CD3OD, and δH 2.50 and δC 39.52 for d6-DMSO. Infrared spectra were recorded on a Bruker Tensor 37 FT-IR. Mass spectra were determined on a Q Exactive Plus (Thermo Scientific) (Blue Scientific Limited, Cambridge, UK) instrument run with positive electrospray ionization (ESI). Melting points were determined on a Stuart SMP10 (Camlab Ltd. Cambridge UK) apparatus and are uncorrected. Optical rotations were measured in a 0.25 dm cell on an ADP440 polarimeter (Bellingham & Stanley Ltd., Weilheim, Germany). Control reactions between 2-hydroxy-1,4-napthoquinone 2 and 3 under standard conditions and between 4-nitrobenzaldehyde 15 and hydroxyacetone 16 under standard conditions, both in the absence of catalyst were determined to show no appreciable levels of conversion over standard reaction timescales.

10. Experimental

10.1. General Methods for the Preparation of Catalysts

Method A: preparation of 7a–e: CDI (2.3 equiv.) was added to a stirred suspension of N,N-dimethyl-l-phenylalanine (2.0 equiv.) in dry DMF (15 mL per mmol of N,N-dimethyl-l-phenylalanine), and the mixture was stirred with gentle warming until dissolved and stirring continued for 1 h. The mixture was then cooled (0 °C), and the diamine (1.0 equiv.) was added. After stirring for 24 h at room temperature, the reaction mixture was rotary evaporated under reduced pressure then co-evaporated with heptane (3 times) to remove DMF. The products 7a–e were purified by repeated column chromatography (0–20% MeOH/CHCl3).
(2S,2′S)-N,N′-(ethane-1,2-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7a.
Method A: Dimethyl-l-phenylalanine (500 mg, 2.60 mmol), 1,2-diaminoethane (78 mg, 1.30 mmol), CDI (484 mg, 2.3 mmol) gave 7a (144 mg, 27%) as a white solid. Rf 0.32 (10% MeOH in CHCl3); Mp. 117 °C; [α]D20 5.2 (c = 1.0, CHCl3); δH 7.09–7.26 (10H, m, 2 × Ph), 6.18 (2H, br s, 2 × NH), 3.12–3.22 (4H, m, 2 × CH2), 3.03 (2H, dd, J 8.4, 12.9, 2 × CH), 2.85–2.96 (2H, m, 2 × CH), 2.79 (2H, dd, J 4.7, 13 Hz, 2 × CH), 2.25 (12H, s, 4 × Me); δC 172.2, 139.6, 129.6, 128.5, 126.3, 71.1, 42.4, 39.0, 33.9; vmax 3303, 2926, 2859, 2828, 2782, 1648, 1536, 1454, 1238. MS (ESI) m/z 206.1 (100%, [M+2H]2+), 411.3, (15%, [M+H]+); HRMS (ESI) m/z found 411.2752, C24H35N4O2+ ([M+H]+) requires 411.2755.
(2S,2′S)-N,N′-(propane-1,3-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7b.
Method A: Dimethyl-l-phenylalanine (750 mg, 3.89 mmol), 1,3-diaminopropane (144 mg, 1.94 mmol), CDI (882 mg, 5.44 mmol) gave 7b (192 mg, 23%) as a white solid. Rf 0.23 (10% MeOH in CHCl3); Mp. 106 °C; [α]D20 +22.4 (c = 1.1, CHCl3); δH 7.24–7.25 (8H, m, 8 × CH), 7.13–7.19 (2H, m, 2 × CH), 6.97 (2H, br t, J 6.2 Hz, 2 × NH) 3.22 (2H, dd, J 5.4, 7.6 Hz, 2 × CH), 3.16 (2H, dd, J 13.3, 7.6 Hz, 2 × CH), 2.92–3.10 (4H, m, 2 × CH2), 2.89 (2H, dd, J 13.3, 5.4 Hz, 2 × CH) 2.32 (12H, s 4 × Me), 1.43 (2H, pentet, J 6.4 Hz, CH2); δC 172.3, 139.7, 129.4, 128.4, 126.2, 71.2, 42.4, 35.8, 33.6, 29.8; vmax 3310, 2973, 2933, 2775, 1639, 1533, 1494, 1266; MS (ESI) m/z 213.1 (100%, [M+2H]2+), (425.3, (98%, [M+H]+); HRMS (ESI) m/z found 425.2910, C24H37N4O2+ ([M+H]+) requires 425.2911.
(2S,2′S)-N,N′-(butane-1,4-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7c.
Method A: Dimethyl-l-phenylalanine (500 mg, 2.59 mmol), 1,4-diaminobutane (114 mg, 1.29 mmol), CDI (503 mg, 3.10 mmol) gave 7c (189 mg, 33%) as a white solid. Rf 0.26 (10% MeOH in CHCl3); Mp. 123 °C; [α]D20 +10.0 (c = 1.0, CHCl3); δH 7.18–7.20 (8H, m, 8 × CH), 7.07–7.13 (2H, m, 2 × CH), 6.80 (2H, br t, J 6.0 Hz, 2 × NH), 3.18 (2H, dd, J 5.4, 7.5 Hz, 2 × CH), 3.02–3.13 (6H, m, 2 × CH, 2 × CH2), 2.81 (2H, dd, J 5.4, 13.5 Hz, 2 × CH), 2.25 (12H, s, 4 × Me), 1.23–1.30 (4H, m, 2 × CH2); δC 172.1, 139.9, 129.4, 128.4, 126.2, 71.0, 42.3, 38.8, 33.0, 27.0; vmax 3310, 2933, 2865, 2827, 2775, 1642, 1535, 1494, 1248; MS (ESI) m/z 220.1 (4%, [M+2H]2+), 439.3, (100%, [M+H]+); HRMS (ESI) m/z found 439.3065, C24H39N4O2+ ([M+H]+) requires 439.3068.
(2S,2′S)-N,N′-(pentane-1,5-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7d.
Method A: Dimethyl-l-phenylalanine (500 mg, 2.58 mmol), 1,5-diaminopentane (132 mg, 1.29 mmol), CDI (502 mg, 3.10 mmol) gave 7d (191 mg, 33%) as a white solid. Rf 0.23 (10% MeOH in CHCl3); Mp. 76 °C; [α]D20 +16.0 (c = 0.96, CHCl3,); δH 7.16–7.19 (8H, m, 8 × CH), 7.08–7.13 (2H, m, 2 × CH), 6.75 (2H, br t, J 6.1 Hz, 2 × NH), 3.05–3.19 (8H, m 4 × CH, 2 × CH2), 2.81 (2H, dd, J 13.4, 5.3 Hz, 2H, 2 × CH); 2.24 (12H, s, 4 × Me), 1.28–1.36 (4H, m, 2 × CH2), 1.07–1.14 (2H, m, CH2); δC 172.0, 139.9, 129.3, 128.4, 126.2, 71.0, 42.3, 38.9, 33.0, 29.3, 24.2; vmax 3310, 2940, 1640, 1536, 1454, 1254; MS (ESI) m/z 227.1 (4%, [M+2H]2+), 445.3, (100%, [M+H]+); HRMS (ESI) m/z found 453.3221, C27H41N4O2+ ([M+H]+) requires 453.3224.
(2S,2′S)-N,N′-(hexane-1,6-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7e.
Method A: Dimethyl-l-phenylalanine (496 mg, 1.29 mmol), 1,6-diaminopropane (150 mg, 1.94 mmol), CDI (502 mg, 3.10 mmol) gave 7b (193 mg, 31%) as a white solid. Rf 0.25 (10% MeOH in CHCl3); Mp. 98 °C; [α]D20 +12 (c = 1.1, CHCl3); δH 7.15–7.23 (8H, m, 8 × CH), 7.06–7.13 (2H, m, 2 × CH), 6.74 (2H, br t, J 5.2 Hz, 2 × NH), 3.02–3.18 (8H, m, 4 × CH2), 2.81 (2H, dd, J 13.1, 5.0 Hz, 2 × CH), 2.24 (12H, s, 4 × Me), 1.25–1.35 (4H, m, 2 × CH2), 1.07–1.21 (4H, m. 2 × CH2); δC 172.1, 140.1, 129.4, 128.4, 126.2, 71.1, 42.4, 39.0, 33.0, 29.5, 26.4; vmax 3306, 2932, 2774, 1643, 1536, 1454, 1249. MS (ESI) 467.3, (100%, [M+H]+). HRMS (ESI) m/z found 467.3378, C28H42N4O2+ ([M+H]+) requires 467.3381.
Method B, preparation of 7a, 7b, 7f, and 10.
General method: (i) CDI (2.2 equiv.) was added in portions over 5 min to a stirred solution of Z-Phe-OH (2.0 equiv.) dissolved in CH2Cl2 (150 mL). After 10 min, the required amine (1.0 equiv.) was added dropwise as a liquid or dissolved in a small volume of CH2Cl2. After 24 h, diethyl ether (100 mL) was added to the solidified mass, which was then filtered through a sinter and the solid washed with 1:1 dichloromethane:diethyl ether until the product was free of imidazole. Drying the product under vacuum gave the required intermediates in 94%, 89%, and 72% yields, respectively. In the case of the intermediate for 10, the product did not precipitate, and thus the reaction was washed with citric acid solution (aq. 10%, 4 × 50 mL), sodium bicarbonate (aq. sat., 2 × 50 mL), and brine (3 × 50 mL), dried (MgSO4) to give the required product in 96% yield. Data for the first two bis-Cbz-protected intermediates was in full agreement with the literature [32]. (ii) The bis-Cbz-protected intermediate (1 equiv.) was suspended in methanol (100 mL per gram), and formaldehyde solution (aq. 37%, 13 equiv.) and Pd/C (10% w/w, 0.50 g per g of starting material) were added. The mixture was vigorously stirred under a hydrogen atmosphere for 5–14 days. The reaction mixture was filtered through celite, which was washed with methanol and evaporated. The mass obtained was co-evaporated with water (3 × 25 mL) to remove excess formaldehyde, then co-evaporated with toluene (2 × 25 mL) to remove water. The residue was dissolved in chloroform, dried (MgSO4), filtered, and evaporated to give the crude products. The products 7a, 7b, 7f, and 10 were purified by column chromatography (0–20% MeOH/CHCl3) and were obtained as solids in 30%, 13%, and 76% yield, respectively. Data for 7a and 7b were identical to that reported above.
(2S,2′S)-N,N′-(heptane-1,7-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 7f.
Method B: (i) Cbz-l-phenylalanine (2.50 g, 8.35 mmol), 1,7-diaminopropane (530 mg, 4.07 mmol), and CDI (1.50 g, 9.25 mmol) gave dibenzyl ((2S,2′S)-(heptane-1,7-diylbis(azanediyl))bis(1-oxo-3-phenylpropane-1,2-diyl))dicarbamate (intermediate) (2.05 g, 2.90 mmol, 72%) as a white solid. Mp. 195–8 °C; [α]D20 +17.1 (c 4.1, DMSO); δH (d6-DMSO) 7.95 (2H, br t, J 5.8 Hz, 2 × NH), 7.48 (2H, br d, J 8.7 Hz, 2 × NH), 7.05–7.35 (20H, m, 4 × Ph), 4.89–4.97 (4H, m, 2 × CH2), 4.16–4.22 (2H, m, 2 × CH), 2.97–3.11 (4H, m, 2 × CH2), 2.93 (2H, dd, J 13.7, 4.9 Hz, 2 × CH), 2.75 (2H, dd, J 13.7, 10.0 Hz, 2 × CH), 1.16–1.50 (10H, m. 5 × CH2); δC (d6-DMSO) 171.1, 155.8, 138.1, 137.1, 129.2, 128.3, 128.0, 127.7, 127.5, 126.2, 65.2, 56.3, 38.5, 37.8, 29.0, 28.5, 26.3; vmax 3299, 3062, 3031, 2936, 2854, 1692, 1648, 1532, 1286, 1258, 1239; MS (ESI) m/z (693.4 (100%, [M+H]+); HRMS (ESI) m/z found 693.3660, C41H49N4O6+ ([M+H]+) requires 693.3647. (ii) The above Cbz-protected intermediate (1.00 g, 1.44 mmol) and formaldehyde (aq. 37%, 1.51 mL, 18.7 mmol) on hydrogenation (Pd/C 10% w/w, 0.50 g) for 5 days gave 7f (0.53 g, 1.10 mmol) in 76% yield as a white solid. Rf 0.25 (10% MeOH in CHCl3); Mp. 93–5 °C; [α]D20 +7.2 (c = 1.0, CHCl3); δH 7.17–7.41 (10H, m, 2 × Ph), 6.91 (2H, br s, 2 × NH), 3.35–3.44 (2H, m, 2 × CH), 3.14–3.26 (6H, m, 2 × CH, 2 × CH2), 2.95 (2H, dd, J 13.7, 4.7 Hz, 2 × CH), 2.40 (12H, s, 4 × Me), 1.37–1.44 (4H, m, 2 × CH2), 1.18–1.31 (6H, m. 3 × CH2); δC 171.5, 139.6, 129.4, 128.5, 126.3, 70.8, 42.2, 39.2, 33.1, 29.5, 28.8, 26.8; vmax 3268, 3086, 3028, 2928, 2858, 2826, 2772, 1641, 1557, 1250; MS (ESI) 241.2 (100%, [M+2H]2+), 481.4, (4%, [M+H]+); HRMS (ESI) m/z found 241.1808, C28H46N4O22+ ([M+2H]2+) requires 241.1805, m/z found 481.3540, C28H45N4O2+ ([M+H]+) requires 481.3537.
(2S,2′S)-N,N′-(2,2-dimethylpropane-1,3-diyl)bis(2-(dimethylamino)-3-phenylpropanamide) 10.
Method B (i) Cbz-l-phenylalanine (3.69 g, 12.33 mmol), 1,3-diamino-2,2-dimethylpropane 9 (0.60 g, 5.87 mmol), CDI (2.19 g, 13.51 mmol) gave dibenzyl ((2S,2′S)-((2,2-dimethylpropane-1,3-diyl)bis(azanediyl))bis(1-oxo-3-phenylpropane-1,2-diyl))dicarbamate (3.76 g, 5.66 mmol) in 96% yield as a white solid. Mp. 91–94 °C; [α]D20 -7.3 (c = 4.0, CHCl3); δH 7.04–7.26 (20H, m, 4 × Ph), 7.00 (2H, br s, 2 × NH), 5.51 (2H, br d, J 8.0 Hz, 2 × NH), 4.90–5.02 (4H, m, 2 × CH2), 4.30–4.47 (2H, m, 2 × CH), 2.79–3.13 (4H, m, 2 × CH2), 2.54–2.93 (2H, m, 2 × CH2) 0.55 (6H, s, 2 × CH3); δC 172.0, 156.1, 136.5, 136.2, 129.4, 128.8, 128.6, 128.3, 128.1, 127.1, 67.1, 56.5, 46.1, 34.8, 36.3, 23.5; vmax 3308, 3063, 3031, 2958, 1701, 1654, 1526, 1497, 1234, 1027, 738, 695; MS (ESI) m/z (665.3 (100%, [M+H]+); HRMS (ESI) m/z found 665.3336, C39H45N4O6+ ([M+H]+) requires 665.3334. (ii) The above Cbz-protected intermediate (1.59 g, 2.39 mmol) and formaldehyde solution (aq. 37%, 2.6 mL, 35.0 mmol) on hydrogenation (Pd/C 10% w/w, 0.50 g) for 5 days gave 10 (0.688 g, 1.48 mmol) in 63% yield as a white solid. Mp. 81–84 °C; [α]D20 +22.5 (c = 4.2, CHCl3); δH 7.07–7.23 (12H, m, 2 × Ph, 2 × NH), 3.22 (2H, dd, J 8.1, 5.5 Hz 2 × CH), 3.08 (2H, dd, J 13.7, 8.1 Hz 2 × CH), 2.86 (2H, dd, J 13.7, 5.5 Hz 2 × CH), 2.62–2.72 (4H, m, 2 × CH2), 2.30 (12H, s, 4 × Me), 0.58 (6H, m. 2 × Me); δC 172.0, 139.2, 129.3, 128.4, 126.2, 71.0, 45.6, 42.3, 36.0, 34.1, 23.6; vmax 3304, 3063, 3030, 2959, 1700, 1653, 1526, 1235, 739, 695; MS (ESI) 227.2 (100%, [M+2H]2+); HRMS (ESI) m/z found 227.1648, C27H42N4O22+ ([M+H]2+) requires 227.1648.
Method C: preparation of 7b. (i) Dibenzyl ((2S,2′S)-(propane-1,3-diylbis(azanediyl))bis(1-oxo-3-phenylpropane-1,2-diyl))dicarbamate [32] (8.12 g, 12.75 mmol, prepared as in Method B, part (i)) was added in portions to HBr in AcOH (35% 100 mL, excess) and the mixture stirred for 4 h. Diethyl ether (100 mL) was added and the supernatant liquid decanted from the precipitated solid. This solid was dissolved in water (100 mL) which was extracted with diethyl ether (3 × 50 mL) then basified (NaOH to pH 12) and then further extracted with chloroform (3 × 100 mL). The combined chloroform extracts were dried (MgSO4), filtered and evaporated to give (2S,2′S)-N,N’-(propane-1,3-diyl)bis(2-amino-3-phenylpropanamide) [32] as a white solid (4.14 g, 11.24 mmol). (ii) This product was dissolved in methanol (50 mL), formaldehyde solution (aq. 37%, 12.1 mL, 0.15 mol) and Pd/C (10% w/w, 1.0 g) were added, and the mixture stirred under a hydrogen atmosphere for 5 days. The mixture was filtered through a celite© pad which was washed with MeOH, and the filtrate evaporated under reduced pressure. After co-evaporation with water (3 × 50 mL) and toluene (2 × 50 mL) the solid residue was dissolved in chloroform, dried (MgSO4), filtered and evaporated. The residue was dissolved in chloroform (100 mL) and extracted with hydrochloric acid (aq. 2N, 40 mL) and the aqueous phase separated and extracted with chloroform (2 × 50 mL) then basified with NaOH (aq. 2M to pH 14) and extracted with chloroform (3 × 50 mL). These extracts were dried and evaporated to give 7b (4.34 g, 10.22 mmol) in 80% yield as a white solid which gave identical data to that reported above.
Method D: Preparation of 10. (i) CDI (2.55 g, 15.8 mmol) was added to a stirred solution of Boc-l-phenylalanine (3.82 g, 14.39 mmol) in CH2Cl2 (50 mL). After 10 min, 1,3-diamino-2,2-dimethylpropane 9 (0.70 g, 6.85 mmol) was added and the mixture stirred for 48 h. The reaction was filtered, and the filtrate washed with citric acid solution (aq. 10%, 4 × 50 mL), sodium bicarbonate (aq. sat., 2 × 50 mL) and brine (3 × 50 mL), dried (MgSO4), filtered and evaporated to give 20 (2.98 g, 4.99 mmol) in 72% yield as a white solid. Mp. 78–82 °C; [α]D20 -9.6 (c = 4.0, CHCl3); δH 7.09–7.24 (10H, m, 4 × Ph), 6.75–6.93 (2H, m, 2 × NH), 5.08 (2H, br d, J 7.7 Hz, 2 × NH), 4.26–4.31 (2H, m, 2 × CH), 2.93–3.03 (4H, m, 2 × CH2), 2.60–2.77 (4H, m, 2 × CH2) 1.34 (18H, s, 6 × CH3), 0.62 (6H, s, 2 × CH3); δC 172.2, 155.6, 136.8, 129.4, 128.7, 127.0, 80.2, 56.2, 46.0, 38.4, 36.4, 36.4, 28.4, 23.6; vmax 3305, 3062, 2974, 2930, 1654, 1524, 1496, 1247, 1164, 698; MS (ESI) m/z (579.4 (100%, [M+H]+); HRMS (ESI) m/z found 597.3648, C33H49N4O6+ ([M+H]+) requires 597.3647. (ii) Compound 20 (1.00 g, 1.67 mmol) was dissolved in dichloromethane (10 mL), cooled (0 °C) and trifluoroacetic acid (5 mL) was added. After stirring overnight, the mixture was evaporated and dissolved in water (15 mL) following which excess NaOH (aq. 2M) was added, and the mixture extracted with chloroform (3 × 50 mL). The combined organic extract were dried (MgSO4), filtered and evaporated to give the diamine which was used in the next step without further purification. (iii) The diamine was dissolved in methanol (5 mL per gram) and formaldehyde solution (aq. 37%, 2.50 mL, 33.6 mmol, 13.0 equiv.) and RaneyNi (10% w/w, 0.25 g) were added. The mixture was vigorously stirred under a hydrogen atmosphere for 5 days and the reaction mixture was filtered through celite under a blanket of nitrogen (CAUTION RaneyNi is prone to ignition in oxygen) which was washed with further methanol. The filtrate was evaporated, and the residue obtained was co-evaporated with water (3 × 25 mL) to remove excess formaldehyde then co-evaporated with toluene (2 × 25 mL) to remove water. The residue was redissolved in chloroform, dried (MgSO4), filtered and evaporated to give 10 (0.55 g, 1.22 mmol) in 73% yield as a gum. Data for 10 was identical to that reported above.
(2S,2′S)-N,N′-(ethane-1,2-diyl)bis(1-methylpyrrolidine-2-carboxamide) 11a.
(2S,2′S)-N,N′-(Ethane-1,2-diyl)bis(pyrrolidine-2-carboxamide) [29] (0.87 g, 3.42 mmol (Prepared by coupling Cbz-l-Pro-OH and ethylene diamine (Method C i), 88%) then HBr/AcOH deprotection (Method D (i), 65%)), formaldehyde solution (aq. 37%, 3.28 mL, 44.0 mmol, 13.0 equiv.) and RaneyNi (10% w/w, 0.25 g) in methanol (5 mL) using Method D (iii) over 7 days (as reported above for 10) gave 11a (0.63 g, 2.23 mmol) in 65% yield as a white solid. Mp. 154–155 °C; Rf 0.23 (10% MeOH in CHCl3); [α]D20 −120.4 (c = 4, CHCl3); δH 7.60 (2H, br s, 2 × NH), 3.29–3.46 (4H, m, 2 × CH2), 3.04–3.12 (2H, m, 2 × CH), 2.88 (2H, dd, J 5.2, 10.2 Hz, 2 × CH), 2.33 (6H, s, 2 × Me), 2.30–2.37 (2H, m, 2 × CH), 2.12–2.24 (2H, m, 2 × CH), 1.63–1.84 (6H, m, 2 × CH, 2 × CH2); δC 175.2, 68.9, 56.7, 41.8, 38.8, 31.1, 24.3; vmax 3275, 2964, 2938, 2872, 3840, 2782, 2763, 1658, 1510, 1457, 1427, 1226, 1048, 745; MS (ESI) 283.2, (10%, [M+H]+); HRMS (ESI) m/z found 283.2126, C14H27N4O2+ ([M+H]+) requires 283.2129.
(2S,2′S)-N,N′-(propane-1,2-diyl)bis(1-methylpyrrolidine-2-carboxamide) 11b.
(2S,2′S)-N,N′-(propane-1,3-diyl)bis(pyrrolidine-2-carboxamide) [28] (Prepared by coupling Cbz-Pro-OH and propane-1,3-diamine (Method C (i), 77%) then HBr/AcOH deprotection (Method D (i), 83%). data for dibenzyl 2,2′-((propane-1,3-diylbis- (azanediyl))bis(carbonyl))(2S,2′S)-bis(pyrrolidine-1-carboxylate; gum, [α]D20 −24 (c = 4.0 CHCl3); δH (d6-DMSO) 7.83–8.02 (2H, m, 2 × NH), 7.19–7.42 (10H, m, 2 × Ph), 4.94–5.13 (4H, m, 2 × CH2), 4.06–4.21 (2H, m, 2 × CH), 3.28–3.55 (4H, m, 2 × CH2), 2.88–3.12 (4H, m, 2 × CH2), 1.91–1.99 (2H, m, 2 × CH), 1.68–1.91 (6H, m, 2 × CH, 2 × CH2), 1.37–1.56 (2H, m. CH2); δC (d6-DMSO) 172.1/172.0/171.8/171.8, 145.1/153.9, 137.0, 128.4/128.3/128.2, 127.8/127.6/127.6/127.5, 127.1/127.0, 65.9/65.8/65.2, 60.3/59.7, 47.1/46.5, 36.1/36.0/36.0/35.8, 31.3/30.2, 29.2, 23.9/23.1; vmax 3292, 3065, 2952, 2879, 1692, 1655, 1532, 1411, 1354, 1239, 1209, 1175, 1118, 1090, 917, 728, 696; MS (ESI) m/z 537.3 (100%, [M+H]+); HRMS (ESI) m/z found 537.2708, C29H37N4O6+ ([M+H]+) requires 537.2708.), 0.63 g, 2.35 mmol), formaldehyde solution (aq. 37%, 2.45 mL, 32.6 mmol, 13.9 equiv.) and RaneyNi (10% w/w, 0.25 g) in methanol (4 mL) using Method D (iii) gave 11b (0.41 g, 1.38 mmol) in 59% yield as a white solid. Mp. 99–102 °C; Rf 0.29 (10% MeOH in CHCl3); [α]D20 −132.0 (c = 4, CHCl3); δH 7.57 (2H, br s, 2 × NH), 3.17–3.31 (4H, m, 2 × CH2), 3.03–3.15 (2H, m, 2 × CH), 2.88 (2H, dd, J 4.8, 9.9 Hz, 2 × CH), 2.35 (6H, s, 2 × Me), 2.28–2.41 (2H, m, 2 × CH), 2.13–2.25 (2H, m, 2 × CH), 1.61–1.86 (8H, m, 2 × CH, 3 × CH2); δC 174.8, 69.0, 56.7, 41.8, 35.7, 31.1, 30.1, 24.2; vmax 3290, 2956, 2940, 2926, 2878, 2744, 1651, 1523, 1457, 1152, 774: MS (ESI) 227.2, (10%, [M+H]+); HRMS (ESI) m/z found 297.2283, C15H29N4O2+ ([M+H]+) requires 297.2285.
(2S,2′S)-N,N′-(2,2-dimethylpropane-1,3-diyl)bis(1-methylpyrrolidine-2-carboxamide) 12.
(i) Cbz-l-proline (2.28 g, 9.15 mmol, 2.10 equiv.), diamine 9 (0.44 g, 4.31 mmol, 1.0 equiv.) and CDI (1.92 g, 11.84 mmol, 2.6 equiv.) gave dibenzyl 2,2′-(((2,2-dimethylpropane-1,3-diyl)bis(azanediyl)) bis(carbonyl))(2S,2′S)-bis(pyrrolidine-1-carboxylate) (2.44 g, 4.32 mmol) in 95% yield as a gum using Method B, part (i). [α]D20 -51 (c = 3.0, CHCl3); δH (mixture of rotamers) 8.08/8.13/8.24/8.39/8.52 (2H, br s, NH), 7.04–7.58 (11H, m, 2 × Ph, NH), 4.90–5.19 (4H, m, 2 × CH2), 4.29–4.38 (2H, m, 2 × CH), 3.39–3.76 (4H, m, 2 × CH2), 2.61–3.10 (4H, m, 2 × CH2) 1.86–2.25 (8H, m, 4 × CH2), 0.61/0.69/0.80/0.88 (6H, br s, 2 × Me); δC 172.6/173.0, 154.9/155.6, 149.3, 148.5, 136.3/136.5, 136.2/137.1, 133.7/133.9, 127.7/127.8/128.0/128.4/128.5/128.7/128.8/129.2/130.0/130.5, 119.7, 117.2, 116.0, 69.9, 67.1, 60.8/61.0, 45.2/45.9/46.6/46.9/47.4, 36.6, 31.4, 29.1/29.4, 24.5/24.7, 23.4/23.6. vmax 3292, 3056, 2952, 2880, 1692, 1655, 1411, 1354, 1090, 728, 696; MS (ESI) 565.3, (100%, [M+H]+); HRMS (ESI) m/z found 565.3020, C31H41N4O6+ ([M+H]+) requires 565.3021. (ii) The above compound (2.33 g, 4.13 mmol) was deprotected with HBr/AcOH as in method C part (ii) to give (2S,2′S)-N,N′-(2,2-dimethylpropane-1,3-diyl)bis(pyrrolidine-2-carboxamide) (1.00 g, 3.38 mmol) in 82% yield as a gum which was used in the next step without further purification. [α]D20 -73.8 (c 2.75, CHCl3); δH (d6-DMSO) 8.13 (2H, t, J 6.8 Hz, 2 × NH), 3.52 (2H, dd, J 5.3, 8.6 2 × CH), 3.33 (2H, br s, 2 × NH obscured), 2.65–2.95 (8H, m, 4 × CH2), 1.83–2.04 (2H, m, 2 × CH) 1.55–1.74 (6H, m, 2 × CH, 2 × CH2), 0.74 (6H, s, 2 × Me); δC 174.8, 60.3, 46.7, 45.0, 36.5, 30.7, 25.8, 23.2; vmax 3359, 3281, 2959, 2870, 1639, 1523; MS (ESI) 149.1, (100%, [M+H]2+); 297.2, (5%, [M+H]+); HRMS (ESI) m/z found 297.2282, C15H29N4O2+ ([M+H]+) requires 297.2285. (ii) The above compound (0.88 g, 2.97 mmol), formaldehyde solution (aq. 37%, 4.7 mL, 63.0 mmol, 21.0 equiv.) and RaneyNi (10% w/w, 0.25 g) in methanol (5 mL) using Method D (iii) (as reported above for 10) gave crude material which was purified by column chromatography (0–2% MeOH in chloroform) gave 12 (0.38 g, 1.14 mmol) in 38% yield as a gum. Rf 0.38 (10% MeOH in CHCl3); [α]D20 -24 (c = 4, CHCl3); δH 7.78 (2H, t, J 7.1 Hz, 2 × NH), 3.10–3.15 (2H, m, 2 × CH), 3.00 (2H, dd, J 6.9, 13.7 Hz, 2 × CH), 2.96 (2H, dd, J 6.9, 13.7 Hz, 2 × CH), 2.88 (2H, dd, J 5.2, 10.2 Hz, 2 × CH), 2.37 (6H, s, 2 × Me), 2.29–2.35 (2H, m, 2 × CH), 2.13–2.24 (2H, m, 2 × CH), 1.71–1.83 (6H, m, 2 × CH, 2 × CH2) 0.85 (6H, s, 2 × CH3); δC 175.1, 69.1, 56.7, 45.4, 41.8, 36.8, 31.3, 24.3, 23.6; vmax 3360, 3283, 2959, 2870, 2845, 2785, 1648, 1518, 1451, 1198, 1179, 979; MS (ESI) 163.1 (100%, [M+2H]2+); 325.3, (15%, [M+H]+); HRMS m/z found 163.1334, C17H32N4O22+ ([M+2H]2+) requires 163.1335; (ESI) m/z found 325.2596, C17H32N4O2+ ([M+H]+) requires 325.2598.

10.2. Preparation of 19a–f and 17a,b

Compounds 18a–f, 20, 22a,b and 24 were prepared using Method D (i). In the case of 18a–f the compounds were isolated by filtration and trituration with diethyl ether. Compounds 18a–e [27,28,29] and 22a,b [28,29] gave data in accordance with the literature.
Di-tert-butyl ((2S,2′S)-(heptane-1,7-diylbis(azanediyl))bis(1-oxo-3-phenylpropane-1,2-diyl))dicarbamate 18f.
Mp. 132–135 °C; [α]D20 +15 (c = 4.0, CHCl3); δH (d6-DMSO, mixture of rotamers) 7.82/7.81–7.90 (2H, br m,/t, J 5.2 Hz, 2 × NH), 7.15–7.27 (10H, m, 2 × Ph) 6.43/6.85 (2H, d/d, J 7.5/8.7 Hz, 2 × NH), 3.95–4.05/4.08–4.13 (2H, m/m 2 × CH), 2.95–3.10 (4H, m, 2 × CH2), 2.89 (2H, dd, J 4.6, 13.0 Hz, 2 × CH) 2.72/2.61–2.77 (2H, dd/m, J 10.2, 13.0 Hz, 2 × CH), 1.30 (18H, s, 2 × tBu), 1.10–1.42 (10 H, m, 5 × CH2); δC 171.3, 155.2, 138.2, 129.2, 128.0, 126.2, 77.9/78.1, 55.8/57.3, 38.3/38.5, 37.8, 29.0, 28.5, 28.2/27.9, 26.3; vmax 3342, 3319, 2964, 2924, 2852, 1683, 1654, 1252, 1171; MS (ESI) 623.4, (100%, [M+H]+); HRMS (ESI) m/z found 625.3960, C35H53N4O6+ ([M+H]+) requires 625.3960.

10.3. Preparation of 19a–f, 21, 23a,b and 25

Compounds 19a–f, 21 and 23a,b were prepared by dissolving the corresponding Boc-protected precursor 18a–f, [25,26,27] 20 or 22a,b [28,29] (0.17 mmol) in chloroform (3 mL) which was cooled (0°C) and trifluoroacetic acid (1–1.5 mL) was added. After stirring at rt for 3 h the reaction was evaporated to dryness and the product dried under vacuum for 24 h. Compound 25 was prepared from diamine 24 (50 mg, 0.17 mmol) by dissolving in chloroform (3 mL) which was cooled (0°C) and trifluoroacetic acid (1 mL) added, then evaporated to dryness under vacuum for 24 h. The catalysts were used directly in the aldol reaction without further purification.
(2S,2′S)-1,1′-(ethane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19a.
White solid, Mp. 155–159 °C; [α]D20 +36.1 (c 6.1, MeOH); δH (d6-DMSO) 8.61 (2H, br s 2 × NH), 8.31 (6H, br s, 6 × NH), 7.03–7.51 (10H, m, 2 × Ph), 3.86–4.01 (2H, m, 2 × CH), 2.84–3.11 (8H, m, 4 × CH2); δC 168.1, 158.7 (C, q, 2JCF 33.6 Hz) 135.1, 129.5, 128.6, 127.2, 116.6 (C, q, JCF 296.5 Hz), 53.8, 38.0, 37.0; vmax 3321, 3112, 2981, 2867, 2823, 1743, 1671, 1552, 1496, 1058, 655; MS (ESI) 178.1, (100%, [M]2+); HRMS (ESI) m/z found 178.1100, C20H28N4O22+ ([M]2+) requires 178.1101.
(2S,2′S)-1,1′-(propane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19b.
Gum; [α]D20 +19.3 (c 10.3, MeOH); δH (d6-DMSO, mixture of rotamers) 8.40 (2H, t, J 5.7 Hz, 2 × NH), 8.03/8.31 (6H, br s, 6 × NH), 7.19–7.32 (10H, m, 2 × Ph), 3.86–4.03 (2H, m, 2 × CH), 2.73–3.07 (8H, m, 4 × CH2), 1.35/1.86 (2H, 2 × pentet, J 7.6/6.7 Hz CH2); δC 167.8, 158.7 (C, q, 2JCF 33.6 Hz) 135.1, 129.5, 128.6, 127.2, 116.5 (C, q, JCF 296.6 Hz), 53.7, 37.2, 36.3/36.4, 25.3/28.3; vmax 3095, 2980, 2873, 1764, 1664, 1499, 1140, 629; MS (ESI) 185.1, (100%, [M]2+); HRMS (ESI) m/z found 185.1179, C21H30N4O22+ ([M]2+) requires 185.1179.
(2S,2′S)-1,1′-(butane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19c.
Gum; [α]D20 +46.5 (c 4.0, MeOH); δH (d6-DMSO) 8.40 (2H, t, J 5.7 Hz, 2 × NH), 8.31 (6H, br s, 6 × NH), 7.19–7.35 (10H, m, 2 × Ph), 3.89–4.03 (2H, m, 2 × CH), 2.81–3.14 (8H, m, 4 × CH2), 1.05–1.26 (4H, m, 2 × CH2); δC 167.8, 158.7 (C, q, 2JCF 34.7 Hz) 135.2, 129.6, 128.6, 127.2, 116.4 (C, q, JCF 294.0 Hz), 53.7, 38.3, 37.3, 26.0; vmax 2941, 1776, 1663, 1137, 700; MS (ESI) 192.1, (100%, [M]2+); HRMS (ESI) m/z found 192.1256, C21H30N4O22+ ([M]2+) requires 192.1257.
(2S,2′S)-1,1′-(pentane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19d.
Gum; [α]D20 +54.2 (c 4.0, MeOH); δH (d6-DMSO) 8.40 (2H, t, J 5.5 Hz, 2 × NH), 8.27 (6H, br s, 6 × NH), 7.19–7.34 (10H, m, 2 × Ph), 3.86–3.98 (2H, m, 2 × CH), 2.93–3.12 (4H, m, 2 × CH, 2 × CH2), 2.81–2.92 (2H, m, 2 × CH), 1.12–1.26 (4H, m, 2 × CH2), 0.90–1.01 (2H, m, CH2); δC 167.5, 158.5 (C, q, 2JCF 35.1 Hz) 135.0, 129.5, 128.5, 127.2, 116.2 (C, q, JCF 293.4 Hz), 53.6, 38.5, 37.2, 28.4, 23.5; vmax 2945, 1763, 1664, 1147, 700; MS (ESI) 199.1, (100%, [M]2+); HRMS (ESI) m/z found 199.1335, C21H30N4O22+ ([M]2+) requires 199.1335.
(2S,2′S)-1,1′-(hexane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19e.
Gum; [α]D20 +39.0 (c 4.0, MeOH); δH (d6-DMSO) 8.34 (2H, t, J 5.5 Hz, 2 × NH), 8.28 (6H, br s, 6 × NH), 7.20–7.33 (10H, m, 2 × Ph), 3.87–4.00 (2H, m, 2 × CH), 3.04–3.14 (2H, m, 2 × CH), 2.99 (4H, d, J 6.3 Hz, 2 × CH2), 2.86–2.96 (2H, m, 2 × CH), 1.12–1.32 (4H, m, 2 × CH2), 0.96–1.12 (4H, m, 2 × CH2); δC 167.9, 158.8 (C, q, 2JCF 35.0 Hz) 139.8, 129.9, 128.9, 127.6, 117.1 (C, q, JCF 296.8 Hz), 54.0, 39.1, 37.6, 29.1, 26.4; vmax 2940, 1763, 1663, 1146, 699; MS (ESI) 206.1, (100%, [M]2+); HRMS (ESI) m/z found 206.1415, C21H30N4O22+ ([M]2+) requires 206.1414.
(2S,2′S)-1,1′-(heptane-1,2-diylbis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 19f.
Gum; [α]D20 +42.9 (c 4.0, MeOH); δH (d6-DMSO) 8.34 (2H, t, J 5.6 Hz, 2 × NH), 8.29 (6H, br s, 6 × NH), 7.20–7.33 (10H, m, 2 × Ph), 3.88–4.00 (2H, m, 2 × CH), 3.06–3.15 (2H, m, 2 × CH), 3.00 (4H, d, J 6.9 Hz, 2 × CH2), 2.86–2.96 (2H, m, 2 × CH), 1.18–1.35 (4H, m, 2 × CH2), 1.02–1.17 (6H, m, 3 × CH2); δC 167.6, 158.6 (C, q, 2JCF 35.8 Hz) 135.1, 129.5, 128.5, 127.2, 116.1 (C, q, JCF 296.0 Hz), 53.6, 38.7, 37.2, 37.6, 28.7, 28.5, 26.3; vmax 2938, 2863, 1776, 1662, 1141, 700; MS (ESI) 213.2, (100%, [M]2+); HRMS (ESI) m/z found 213.1492, C21H30N4O22+ ([M]2+) requires 213.1492.
(2S,2′S)-1,1′-((2,2-Dimethylpropane-1,3-diyl)bis(azanediyl))bis(1-oxo-3-phenylpropan-2-aminium) bistrifluoroacetate salt 21.
Gum; [α]D20 +45.8 (c 4.0, MeOH); δH (d6-DMSO) 8.21 (6H, s 6 × NH), 8.22 (2H, t, J 5.4 Hz, 2 × NH), 7.20–7.42 (10H, m, 2 × Ph), 3.99–4.15 (2H, m, 2 × CH), 3.01 (4H, d, J 7.3 Hz, 2 × CH2), 2.85 (2H, dd, J 6.7, 13.5 Hz, 2 × CH), 2.85 (2H, dd, J 5.7, 13.5 Hz, 2 × CH), 0.56 (6H, s, 2 × Me); δC 168.5, 158.8 (C, q, 2JCF 35.7 Hz), 135.1, 129.6, 128.8, 127.4, 116.1 (C, d, JCF 269.6 Hz), 53.8, 46.7, 37.4, 36.2, 25.9; vmax 2968, 1764, 1666, 1145, 699; MS (ESI) 199.1, (100%, [M]2+); HRMS (ESI) m/z found 199.1334, C23H36N4O22+ ([M]2+) requires 199.1335.
(2S,2′S)-2,2′-((ethane-1,2-diylbis(azanediyl))bis(carbonyl))bis(pyrrolidin-1-ium) bistrifluoroacetate salt 23a.
Gum; [α]D20 −22.8 (c 4.0, MeOH); δH (d6-DMSO) 9.81 (2H, br s, 2 × NH), 8.68–8.78 (2H, m, 2 × NH), 8.53 (2H, br s, 2 × NH), 4.09–4.19 (2H, m, 2 × CH), 3.12–3.30 (8H, m, 2 × CH2), 2.18–2.30 (2H, m, 2 × CH), 1.80–1.92 (6H, m, 2 × CH, 2 × CH2); δC 168.4, 158.8 (C, q, 2JCF 34.7 Hz), 116.8 (C, d, JCF 295.1 Hz), 59.1, 45.7, 38.5, 29.5, 23.6; vmax 3290, 3085, 2992, 2958, 1665, 1572, 1169, 1131, 835, 796, 720, 678; MS (ESI) 128.1 (100%, [M]2+); HRMS (ESI) m/z found 128.0942, C12H24N4O22+ ([M]2+) requires 128.0944.
(2S,2′S)-2,2′-((ethane-1,2-diylbis(azanediyl))bis(carbonyl))bis(pyrrolidin-1-ium) bistrifluoroacetate salt 23b.
Gum; [α]D20 −36.7 (c 4.0, MeOH); δH (d6-DMSO) 9.63–9.96 (2H, br m, 2 × NH), 8.63 (2H, t, J 5.6 Hz, 2 × NH), 8.44–8.59 (2H, br m, 2 × NH), 4.08–4.27 (2H, m, 2 × CH), 3.06–3.33 (8H, m, 4 × CH2), 2.18–2.39 (2H, m, 2 × CH), 1.75–1.97 (6H, m, 2 × CH, 2 × CH2), 1.53–1.70 (2H, m, CH2); δC 168.2, 159.0 (C, q, 2JCF 35.4 Hz), 116.5 (C, q, JCF 292.8 Hz), 59.2, 45.7, 36.7, 29.8, 28.7, 23.7; vmax 3290, 3092, 2967, 1779, 1665, 1567, 1168, 1132, 835, 797, 721, 704; MS (ESI) 135.1 (100%, [M]2+); HRMS (ESI) m/z found 135.1021, C13H26N4O22+ ([M]2+) requires 135.1022.
Di-tert-butyl ((2S, 2′S, 3R, 3′R)-(ethane-1,2-diylbis(azanediyl))bis(3-hydroxy-1-oxobutane-1,2-diyl))dicarbamate 25.
EDC.HCl (887 mg, 4.63 mmol, 2.30 equiv.), HOBt.H2O (840 mg, 6.50 mmol, 3.23 equiv.), DIPEA (0.79 mL, 585 mg, 4.52 mmol, 2.25 equiv.) and DMAP (50 mg, 0.41 mmol, 0.20 equiv.) were added sequentially to a cooled (0 °C) solution of l-Boc-Thr 24 (908 mg, 4.14 mmol, 2.06 equiv.) in dry DMF (40 mL) After 1 h, ethylene diamine 8a (n = 0, 121 mg, 0.134 mL, 2.01 mmol, 1.00 equiv.) was added and the resulting mixture was stirred to rt for 48 h. The mixture was diluted with EtOAc (150 mL), washed with NaHCO3 solution (aq., sat. 2 × 50 mL) and brine (2 × 100 mL), then dried (MgSO4) and evaporated under reduced pressure. Column chromatography of the crude product (0–2% MeOH in CH2Cl2) gave 25 (645 mg, 1.39 mmol) in 69% yield as a white solid. [α]D20 +14.5 (c 4.0, CHCl3); Mp. 82–85 °C; δH 7.19–7.36 (2H, br m, 2 × NH), 5.72–5.94 (2H, br m, 2 × NH), 4.28–5.39 (2H, br m, 2 × CH), 4.18 (2H, br s, 2 × OH) 4.04 (2H, br d, J 6.0 Hz, 2 × CH), 3.44–3.61 (2H, br m, 2 × CH), 3.19–3.26 (2H, br m, 2 × CH), 1.43 (18H, s, 6 × Me), 1.17 (6H, d, J 6.0 Hz, 2 × Me); δC 172.9, 156.5, 80.5, 67.2, 59.8, 39.8, 28.4, 19.3; vmax 3326, 2978, 2935, 1688, 1649, 1497, 1366, 1248, 1161, 910, 729; MS (ESI) 463.3 (100%, [M+H]+); HRMS (ESI) m/z found 463.2753, C20H38N4O8+ ([M+H]+) 463.2762.
(2S, 2′S, 3R, 3′R)-1,1′-(ethane-1,2-diylbis(azanediyl))bis(3-hydroxy-1-oxobutan-2-aminium) bistrifluoroacetate 26.
Compound 25 (105 mg, 0.228 mmol) was dissolved in chloroform (4 mL), cooled (0 °C) and trifluoroacetic acid (2 mL) was added. After stirring to rt over 24 h the reaction was evaporated to dryness and the product dried under vacuum for 24 h to give 26 (109 mg) as a gum. This was used directly in the aldol reaction without further purification. [α]D20 +3.6 (c 2.7, MeOH); δH 8.63–8.70 (2H, br m, 2 × NH), 8.01–8.22 (4H, br m, 2 × NH2), 6.73–8.34 (2H, br s, 2 × OH), 3.85–3.93 (2H, m, 2 × CH), 3.42–3.54 (2H, m, 2 × CH), 3.08–3.31 (4H, m, 2 × CH2), 1.12 (6H, d, J 6.3 Hz); δC 167.2, 158.6 (C, q, 2JCF 35.8 Hz), 116.3 (C, q, JCF 296.0 Hz), 65.7, 58.5, 38.2, 20.0; vmax 3254, 3087, 2983, 1662, 1534, 1169, 1181, 1130, 839, 799, 722; MS (ESI) 132.1 (100%, [M]2+), 263.2 (25%, [M-H]+); HRMS (ESI) m/z found 103.0892, C21H30N4O22+ ([M]2+) requires 103.0893; m/z found 263.1712, C21H30N4O22+ ([M-H]+) requires 263.1714.

10.4. General Method for the Reaction of 2-Hydroxy-1,4-napthoquinone 1 with β-Nitrostyrene 2

2-Hydroxy-1,4-napthoquinone 1 (100 mg, 0.574 mmol) and the required catalyst (0.1 equiv.) were dissolved in the requisite solvent (10 mL) and cooled (−20 °C). β-Nitrostyrene 2 (128.5 mg, 0.861 mmol, 1.5 equiv.) was then added and the mixture stirred for the required time and temperature. On completion the solvent was evaporated to give a deep red residue which was purified by column chromatography (2–4% EtOAc in petroleum ether to remove excess 2 then CH2Cl2) to give 3 as a yellow solid. Enantiomeric excesses were determined on a CHIRALPAK IA column (250 × 4.6 mm) with 90% hexane with 0.1% TFA, 8% ethanol and 2% dichloromethane as the mobile phase detecting at 254 nm. For a 44% ee sample, S enantiomer 18.1 min, R enantiomer 24.2 min, [α]D22 −12.1 (acetone, c 1.52; lit. [α]D17 −44.8 (acetone, c 1.0) [33], lit. [α]D25 −34 (acetone, c 1.0) [34].

10.5. General Method for the Aldol Reaction between 4-Nitrobenzaldehyde 15 and Hydroxyacetone 16

The catalyst (0.2 equiv) was dissolved in the required solvent, p-nitrobenzaldehyde 15 (1 equiv.) was added and once dissolved hydroxyacetone 16 (10–20 equiv.). The solution was stirred for the required time, diluted with water (250 mL) and the mixture extracted with ethyl acetate (3 × 50 mL). The combined organic layers were dried with magnesium sulphide, filtered and evaporated. Analysis by 1H NMR gave the conversion and syn:anti ratio (see SI). Purification by column chromatography (eluting with 10% EtOAc in petroleum ether to remove unreacted 15 was followed by 40–60% EtOAc in petroleum ether) combination of the fractions containing 17 was followed by HPLC analysis to determine ee (see SI). Selected data for the syn-17 diol δH = 5.20 (1H, d, J 2.7 Hz) and 5.20 (1H, d, J 2.7 Hz) ppm and the anti-17 diol, δH = 5.03 (1H, d, J 4.6 Hz) and 4.41 (1H, d, J 4.6 Hz) ppm. HPLC data:20 Diacel chiralpak AD (250 × 4.6 mm), hexane/i-PrOH = 90:10, flow rate 1.0 mL/min, λ = 254 nm: tR = 18.4 min (Major anti enantiomer, (3S,4S)), tR = 21.3 min (Minor anti enantiomer, (3R,4R)), tR = 26.7 min (Minor syn enantiomer (3S,4R)) and tR = 37.8 min (Major syn enantiomer, (3R,4S)). Phonemenex Lux® 3 µm Amylose-1 column (150 × 4.6 mm), hexane/i-PrOH = 90:10, flow rate 1 mL/min, λ = 209 nm: tR = 14.7 min (Major anti enantiomer, (3S,4S)), tR = 16.0 min (Minor anti enantiomer, (3R,4R)), tR = 19.4 min (Minor syn enantiomer (3S,4R)) and tR = 22.9 min (Major syn enantiomer, (3R,4S)).

11. Crystallography

A single colourless needle-shaped crystal of 11a with dimensions 0.340 × 0.025 × 0.020 mm3 was mounted on a Rigaku 007HF diffractometer with HF Varimax confocal mirrors, a UG2 goniometer and HyPix 6000HE detector. The crystal was kept at a steady T = 100(2) K during data collection. Table 3 contains the basic crystallographic data. CCDC2211459 contains supplementary X-ray crystallographic data for 11a. This data can be obtained free of charge via http://www.ccdc.cam.ac.uk/structures/ (accessed on 15 August 2024), or from the Cambridge Crystallographic Data Centre, Union Road, Cambridge, CB2 1EZ; fax (+44) 1223-336-033 or email: [email protected].

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/reactions5030027/s1. HPLC data for Michael adduct 3, HPLC data for Aldols 17, Catalysed reactions of acetylacetone or 1,3-diphenyl-1,3-propanedione with β-Nitrostyrene 2 and NMR spectra for all new compounds.

Author Contributions

Conceptualization, P.J.M.; methodology, Z.S.A.-T., D.F., L.G., P.K., P.J.M., N.B.W., O.T.W.; formal analysis, Z.S.A.-T., S.J.C., A.C., P.N.H., L.F.J., R.K., P.J.M., G.J.T., O.T.W.; investigation, Z.S.A.-T., D.F., L.G., P.K., P.J.M., N.B.W., O.T.W., resources, S.J.C., A.C., P.N.H., R.K., P.J.M., G.J.T.; writing—original draft preparation, P.J.M.; writing—review and editing, Z.S.A.-T., S.J.C., D.F., L.G., P.N.H., L.F.J., P.K., P.J.M., N.B.W., O.T.W.; supervision, P.J.M.; project administration, P.J.M.; funding acquisition, P.J.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded in part by the Iraqi government (Z.S.A.-T.) and supported by the Centre for Environmental Biotechnology Project part-funded by the European Regional Development Fund (ERDF; RK) through the Welsh Government. Support was given by the EPSRC via the EPSRC National Crystallography Service.

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

Acknowledgments

The authors would like to thank the Iraqi government (Z.S.A.-T.) and acknowledge the support of the Centre for Environmental Biotechnology Project part-funded by the European Regional Development Fund (ERDF; RK) through the Welsh Government. We also thank the EPSRC National Crystallography Service at the University of Southampton.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Han, B.; He, X.-H.; Liu, Y.-Q.; He, G.; Peng, C.; Li, J.-L. Asymmetric organocatalysis: An enabling technology for medicinal chemistry. Chem. Soc. Rev. 2021, 50, 1522–1586. [Google Scholar] [CrossRef] [PubMed]
  2. Scheffler, U.; Mahrwald, R. Recent Advances in Organocatalytic Methods for Asymmetric C–C Bond Formation. Chemistry—A Eur. J. 2013, 19, 14346–14396. [Google Scholar] [CrossRef] [PubMed]
  3. Chanda, T.; Zhao, J.C.-G. Recent Progress in Organocatalytic Asymmetric Domino Transformations. Adv. Synth. Catal. 2018, 360, 2–79. [Google Scholar] [CrossRef]
  4. Pellissier, H. Asymmetric organocatalysis. Tetrahedron 2007, 63, 9267–9331. [Google Scholar] [CrossRef]
  5. Yeşil, T.A.; Atalar, T.; Yavuz, M.; Ertürk, E. Prolinamides derived from 2-aminocyclohexanols as organocatalysts for asymmetric List-Lerner-Barbas aldol reactions. Tetrahedron Lett. 2024, 140, 155042. [Google Scholar] [CrossRef]
  6. Alhoussein, J.; Marrot, J.; Wright, K.; Couty, F.; Moreau, X.; Drouillat, B. Synthesis of 2-tetrazolyl azetidines and their evaluation in organocatalysis. Tetrahedron 2024, 158, 134002. [Google Scholar] [CrossRef]
  7. Yıldız, T.; Hasdemir, B.; Yaşa, H.; Küçük, H.B. New Strategy for the Synthesis of Some Valuable Chiral 1,3-Diols with High Enantiomeric Purity: New Organocatalyst, Asymmetric Aldol Reaction, and Reduction. ACS Omega 2024, 9, 12657–12664. [Google Scholar] [CrossRef] [PubMed]
  8. Magham, L.R.; Samad, A.; Thopate, S.B.; Nanubolu, J.B.; Chegondi, R. Organocatalytic enantioselective desymmetrization of enal-tethered cyclohexane-1,3-diones. Chem. Commun. 2024, 60, 3834–3837. [Google Scholar] [CrossRef]
  9. Hosseini-Dastjerdi, F.; Zandieh, H.; Yari, A.; Mokhtari, J.; Karimian, K. N-PEGylated (L)-Prolinamide: A Homogeneous, Solvent-Free, and Recyclable Catalyst for Scalable Enantioselective Aldol Reaction. Catal. Lett. 2024, 154, 4009–4021.
  10. Zárate-Roldán, S.; Trujillo-Rodríguez, M.J.; Gimeno, M.C.; Herrera, R.P. L-proline-based deep eutectic solvents as green and enantioselective organocatalyst/media for aldol reaction. J. Mol. Liq. 2024, 396, 123971. [Google Scholar] [CrossRef]
  11. Al-Taie, Z.S.; Anetts, S.R.; Christensen, J.; Coles, S.J.; Horton, P.N.; Evans, D.M.; Jones, L.F.; de Kleijne, F.F.J.; Ledbetter, S.M.; Mehdar, Y.T.H.; et al. Proline derived guanidine catalysts forge extensive H-bonded architectures: A solution and solid state study. RSC Adv. 2020, 10, 22397–22416. [Google Scholar] [CrossRef] [PubMed]
  12. Al-Taie, Z.S.; Anderson, J.M.; Bischoff, L.; Christensen, J.; Coles, S.J.; Froom, R.; Gibbard, M.E.; Jones, L.F.; de Kleijn, F.F.J.; Murphy, P.J.; et al. N-carbamate protected amino acid derived guanidine organocatalysts. Tetrahedron 2021, 89, 132093. [Google Scholar] [CrossRef]
  13. Tang, G.; Gün, Ü.; Altenbach, H. Novel aminoimidazole derived proline organocatalysts for aldol reactions. Tetrahedron 2012, 68, 10230–10235. [Google Scholar] [CrossRef]
  14. Bhowmick, S.; Kunte, S.S.; Bhowmick, K.C. The smallest organocatalyst in highly enantioselective direct aldol reaction in wet solvent-free conditions. Tetrahedron RSC Adv. 2014, 4, 24311–24315. [Google Scholar] [CrossRef]
  15. Yamagata, A.D.G.; Dixon, D.J. Enantioselective Construction of the ABCDE Pentacyclic Core of the Strychnos Alkaloids. Org. Lett. 2017, 19, 1894–1897. [Google Scholar] [CrossRef]
  16. Bowman, R.E.; Stroud, H.H. N-substituted amino-acids. Part I. A new method of preparation of dimethylamino-acids. J. Chem. Soc. 1950, 1342–1345. [Google Scholar] [CrossRef]
  17. Salvio, R.; Mandolini, L.; Savelli, C. Guanidine−Guanidinium Cooperation in Bifunctional Artificial Phosphodiesterases Based on Diphenylmethane Spacers; gem-Dialkyl Effect on Catalytic Efficienc. J. Org. Chem. 2013, 78, 7259–7263. [Google Scholar] [CrossRef]
  18. Jeffrey, G.A. An Introduction to Hydrogen Bonding; Oxford University Press: New York, NY, USA; Oxford, UK, 1997; ISBN 0-19-509549-9. [Google Scholar]
  19. Herschlag, D.; Pinney, M.M. Hydrogen Bonds: Simple after All? Biochemistry 2018, 57, 3338–3352. [Google Scholar] [CrossRef]
  20. Fang, B.; Liu, X.; Zhao, J.; Tang, Y.; Lin, L.; Feng, X. Chiral Bifunctional Guanidine-Catalyzed Enantioselective Aza-Henry Reaction of Isatin-Derived Ketimines. J. Org. Chem. 2015, 80, 3332–3338. [Google Scholar] [CrossRef]
  21. Samanta, S.; Liu, J.; Dodda, R.; Zhao, C.-G. C2-symmetric bisprolinamide as a highly efficient catalyst for direct aldol reaction. Org. Lett. 2005, 7, 5321–5323. [Google Scholar] [CrossRef]
  22. Jimeno, C. Amino Acylguanidines as Bioinspired Catalysts for the Asymmetric Aldol Reaction. Molecules 2021, 26, 826. [Google Scholar] [CrossRef] [PubMed]
  23. Valapil, G.; Kadagathur, M.; Shankaraiah, N. Stereoselective Aldol and Conjugate Addition Reactions Mediated by Proline-Based Catalysts and Its Analogues: A Concise Review. Eur. J. Org. Chem. 2021, 7, 5288–5311. [Google Scholar] [CrossRef]
  24. Yadav, G.D.; Deepa; Singh, S. Prolinamide-Catalysed Asymmetric Organic Transformations. Chem. Sel. 2019, 4, 5591–5618. [Google Scholar] [CrossRef]
  25. Wiznycia, A.V.; Rush, J.R.; Baures, P.W. Synthesis of Symmetric Bis(imidazole-4,5-dicarboxamides) Substituted with Amino Acids. J. Org. Chem. 2004, 69, 8489–8491. [Google Scholar] [CrossRef] [PubMed]
  26. Lyakhov, S.A.; Suveyzdis, Y.I.; Litvinova, L.A.; Andronati, S.A.; Rybalko, S.L.; Dyadyun, S.T. Biological active acridine derivatives. Part 4: Synthesis and antiviral activity of some bis-acridinylated diamides. Pharmazie 2000, 55, 733–736. [Google Scholar]
  27. Kobayashi, S.; Atuchi, N.; Kobayashi, H.; Shiraishi, A.; Hamashima, H.; Tanaka, A. Diastereomeric Selective Effects for Growth Inhibition of Synthesized Mini Parallel Double-Stranded Peptides on Escherichia coli and Staphylococcus aureus. Chem. Pharm. Bull. 2004, 52, 204–213. [Google Scholar] [CrossRef]
  28. Wang, Z.; Wei, S.; Wang, C.; Sun, J. Enantioselective hydrosilylation of ketimines catalyzed by Lewis basic C2-symmetric chiral tetraamide. Tetrahedron Asymmetry 2007, 18, 705–709. [Google Scholar] [CrossRef]
  29. Al-Azemi, T.F.; Mohamod, A.A.; Vinodh, M. Ring-closing metathesis approach for the synthesis of optically active L-proline-based macrocycles. Tetrahedron 2015, 71, 1523–1528. [Google Scholar] [CrossRef]
  30. Guillena, G.; Hita, M.d.C.; Nájera, C. Organocatalyzed direct aldol condensation using L-proline and BINAM-prolinamides: Regio-, diastereo-, and enantioselective controlled synthesis of 1,2-diols. Tetrahedron-Asymmetry 2006, 17, 1027–1031. [Google Scholar] [CrossRef]
  31. Ramasastry, S.S.V.; Zhang, H.; Tanaka, F.; Barbas, C.F. Direct Catalytic Asymmetric Synthesis of anti-1,2-Amino Alcohols and syn-1,2-Diols through Organocatalytic anti-Mannich and syn-Aldol Reactions. J. Am. Chem. Soc. 2007, 129, 288–289. [Google Scholar] [CrossRef]
  32. Becerril, J.; Bolte, M.; Burguete, M.I.; Galindo, F.; García-España, E.; Luis, S.V.; Miravet, J.F. Efficient macrocyclization of U-turn preorganized peptidomimetics: The role of intramolecular H-bond and solvophobic effects. J. Am. Chem. Soc. 2003, 125, 6677–6686. [Google Scholar] [CrossRef] [PubMed]
  33. Woo, S.B.; Kim, D.Y. Enantioselective Michael addition of 2-hydroxy-1,4-naphthoquinones to nitroalkenes catalyzed by binaphthyl-derived organocatalysts. Beilstein J. Org. Chem. 2012, 8, 699–704. [Google Scholar] [CrossRef] [PubMed]
  34. Yang, W.; Du, D. Chiral Squaramide-Catalyzed Highly Enantioselective Michael Addition of 2-Hydroxy-1,4-naphthoquinones to Nitroalkenes. Adv. Synth. Catal. 2011, 353, 1241–1246. [Google Scholar] [CrossRef]
Scheme 1. Catalytic Michael addition: Catalyst (0.1 equiv.), −20 °C, 48 h.
Scheme 1. Catalytic Michael addition: Catalyst (0.1 equiv.), −20 °C, 48 h.
Reactions 05 00027 sch001
Figure 1. Generalised catalyst structure (n = 0–5).
Figure 1. Generalised catalyst structure (n = 0–5).
Reactions 05 00027 g001
Scheme 2. Method A: N,N-dimethyl-l-phenylalanine (2.1 equiv.), CDI (2.3 equiv.), DMF, 1 h. then amine 8a–f (1 equiv.), 24 h. Method B: (i) Cbz-l-Phe-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then amine 8a–f (1 equiv.), 16 h. (ii) CH2O (aq. 37%, 13 equiv.), H2/Pd/C, MeOH, 48 h. Method C: Cbz-l-Phe-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then 9 (1 equiv.), 16 h. (ii) HBr in AcOH (33%, excess) then NaOH (aq). (iii) CH2O (aq. 37%, 13 equiv.), H2/Pd/C, MeOH, 48 h. Method D: (i) Boc-l-Phe-OH or Boc-l-Pro-OH or Cbz-l-Pro-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then 8a,b or 9 (1 equiv.), 16 h. (ii) CF3CO2H/CHCl3 (1:2, excess) then NaOH (aq) or HBr in AcOH (33%, excess) then NaOH (aq). (iii) CH2O (aq. 37%, 13 equiv.), H2/Raney Ni, MeOH, 96 h. (n = 0–5).
Scheme 2. Method A: N,N-dimethyl-l-phenylalanine (2.1 equiv.), CDI (2.3 equiv.), DMF, 1 h. then amine 8a–f (1 equiv.), 24 h. Method B: (i) Cbz-l-Phe-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then amine 8a–f (1 equiv.), 16 h. (ii) CH2O (aq. 37%, 13 equiv.), H2/Pd/C, MeOH, 48 h. Method C: Cbz-l-Phe-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then 9 (1 equiv.), 16 h. (ii) HBr in AcOH (33%, excess) then NaOH (aq). (iii) CH2O (aq. 37%, 13 equiv.), H2/Pd/C, MeOH, 48 h. Method D: (i) Boc-l-Phe-OH or Boc-l-Pro-OH or Cbz-l-Pro-OH (2.1 equiv.), CDI (2.3 equiv.), CH2Cl2, 10 min, then 8a,b or 9 (1 equiv.), 16 h. (ii) CF3CO2H/CHCl3 (1:2, excess) then NaOH (aq) or HBr in AcOH (33%, excess) then NaOH (aq). (iii) CH2O (aq. 37%, 13 equiv.), H2/Raney Ni, MeOH, 96 h. (n = 0–5).
Reactions 05 00027 sch002
Scheme 3. Catalytic studies: Conditions: See Table 2, catalyst (0.1 equiv.), −20 °C, CH2Cl2.
Scheme 3. Catalytic studies: Conditions: See Table 2, catalyst (0.1 equiv.), −20 °C, CH2Cl2.
Reactions 05 00027 sch003
Figure 2. Crystal structure of 11a. The colour codes used throughout this work are Grey (C), Red (O), Blue (N) and black (H). The majority of H-atoms have been omitted for clarity. Only one form of the disordered connecting diamide bridges is shown. The dashed lines represent intramolecular H-bonds (N1(H1)N2 = 2.39(4) Å (′ = 1 − x, 1 − y, z).
Figure 2. Crystal structure of 11a. The colour codes used throughout this work are Grey (C), Red (O), Blue (N) and black (H). The majority of H-atoms have been omitted for clarity. Only one form of the disordered connecting diamide bridges is shown. The dashed lines represent intramolecular H-bonds (N1(H1)N2 = 2.39(4) Å (′ = 1 − x, 1 − y, z).
Reactions 05 00027 g002
Figure 3. Packing arrangement of 11a as viewed along the ab plane of the unit cell. The dashed lines represent intermolecular H-bonding interactions at a distance of O1⋯N1′(H1′) = 2.06(4) Å (′ = x, y, 1 + z; ″ = x, y, −1 + x). Only one form of the disordered connecting diamide bridges is shown.
Figure 3. Packing arrangement of 11a as viewed along the ab plane of the unit cell. The dashed lines represent intermolecular H-bonding interactions at a distance of O1⋯N1′(H1′) = 2.06(4) Å (′ = x, y, 1 + z; ″ = x, y, −1 + x). Only one form of the disordered connecting diamide bridges is shown.
Reactions 05 00027 g003
Scheme 4. Aldol reaction catalysed by 13 or 14. (a) Catalyst 13 (10 mol%), THF; 38% yield. (b) Catalyst 14 (20 mol%), DMF; 75% conversion.
Scheme 4. Aldol reaction catalysed by 13 or 14. (a) Catalyst 13 (10 mol%), THF; 38% yield. (b) Catalyst 14 (20 mol%), DMF; 75% conversion.
Reactions 05 00027 sch004
Scheme 5. (a) Boc-l-Phe-OH (2.10 equiv.), CDI (2.60 equiv.), CH2Cl2, 10 min, then 8a–f (1.00 equiv.), 16 h. (b) CF3CO2H/CHCl3 (1:2, excess), 4 h. (c) Cbz-l-Pro-OH (2.10 equiv.), CDI (2.60 equiv.), CH2Cl2, 10 min, then 9 (1.00 equiv.), 16 h. (n = 0–5).
Scheme 5. (a) Boc-l-Phe-OH (2.10 equiv.), CDI (2.60 equiv.), CH2Cl2, 10 min, then 8a–f (1.00 equiv.), 16 h. (b) CF3CO2H/CHCl3 (1:2, excess), 4 h. (c) Cbz-l-Pro-OH (2.10 equiv.), CDI (2.60 equiv.), CH2Cl2, 10 min, then 9 (1.00 equiv.), 16 h. (n = 0–5).
Reactions 05 00027 sch005
Scheme 6. Preparation of 26 (a) (i) 24 (2.0 equiv.), EDC.HCl (2.30 equiv.), HOBt.H2O (3.23 equiv.), DIPEA (2.25 equiv.), DMAP (0.20 equiv.), then (ii) 8a (n = 0, 1.00 equiv.). (b) CF3CO2H/CHCl3 (1:2, excess), 4 h.
Scheme 6. Preparation of 26 (a) (i) 24 (2.0 equiv.), EDC.HCl (2.30 equiv.), HOBt.H2O (3.23 equiv.), DIPEA (2.25 equiv.), DMAP (0.20 equiv.), then (ii) 8a (n = 0, 1.00 equiv.). (b) CF3CO2H/CHCl3 (1:2, excess), 4 h.
Reactions 05 00027 sch006
Figure 4. Aldol transition states proposed by Jimeno [11] and Barbas. [16].
Figure 4. Aldol transition states proposed by Jimeno [11] and Barbas. [16].
Reactions 05 00027 g004
Table 1. Preparation of catalysts 7a–f and 10.
Table 1. Preparation of catalysts 7a–f and 10.
EntryCatalystnA/%B/%C/%D/%
17a02730------
27b1231380---
37c233---------
47d332---------
57e431---------
67f5---76------
710------63---73
811a0---------65
911b1---------59
1012------------38
Table 2. Catalysed Michael reaction between 1 and 2.
Table 2. Catalysed Michael reaction between 1 and 2.
EntryCat.nTime/deeYield/%
17a042689
27b144470
37c243677
47d344492
57e442796
67f541992
710-43885
811a041039
911a0141587
1011b14998
1112-41569
Table 3. X-ray crystallographic data obtained from 11a.
Table 3. X-ray crystallographic data obtained from 11a.
11a
FormulaC14H26N4O2
MW282.388
Crystal SystemOrthorhombic
Space groupP21212
a13.7087(5)
b11.6393(4)
c5.0039(2)
α/o90
β/o90
γ/o90
V3798.42(5)
Z2
T/K100(2)
λ1.54178
Dc/g cm−31.175
μ(Mo-Ka)/mm−10.645
Meas./indep.(Rint) refl.7332/1497 (0.0350)
Restraints, Parameters0.109
wR2 (all data)0.1843
R10.0867
Goodness of fit on F21.042
Table 4. Aldol reaction of 15 and 16 catalysed by 19a–f, 21 and 23a,b (i).
Table 4. Aldol reaction of 15 and 16 catalysed by 19a–f, 21 and 23a,b (i).
EntryCat.T
(d)
nConversion (%)syn:antiSyn
ee
Anti
ee
119a205862:385072
219b213563:374846
319c223266:343436
419d233262:383242
519e243268:323038
619f253261:393240
7212--4666:343236
819a4063 (ii)57:433634
919b4163 (ii)62:382036
10214--62 (ii)63:372432
1119a4080 (ii),(iii)51:495260
1219b4172 (ii),(iii)57:433860
13214--86 (ii),(iii)62:384024
1419a4090 (iii),(iv)50:503626
1519b4188 (iii),(iv)56:441439
16214--83 (iii),(iv)55:451614
1723a406252:48−30 (v)−28 (v)
1823b414852:48−24 (v)−24 (v)
(i) General conditions catalyst (0.2 equiv.), 15 (1.0 equiv.), 16 (10 equiv. unless stated), DMF (0.33 M relative to 15), rt. (ii) Compound 15 used at 0.66 M; (iii) 20 equiv. of 16; (iv) Reagent 16 used as solvent (0.33 M relative to 15); (v) Opposite enantiomeric selectivity observed.
Table 5. Aldol reaction of 15 and 16 catalysed by 19a in differing solvents (i).
Table 5. Aldol reaction of 15 and 16 catalysed by 19a in differing solvents (i).
EntrySolventConversion
(%)
syn:antisyn eeAnti ee
0DMF5862:385072
1THF7547:535482
2EtOH7347:535460
3iPrOH5240:605070
4MeCN4448:525072
5DMSO1963:37ndnd
6MeOH1880:20ndnd
7CH2Cl21233:67ndnd
8(CH2OH)21050:50ndnd
9Water0------
(i) General conditions. Catalyst (0.2 equiv.), 15 (1.0 equiv.), 16 (10 equiv.), solvent (0.33 M relative to 15), rt. nd = not determined.
Table 6. Aldol reaction of 15 and 16 catalysed by 0.2 equivalents of 19a in differing solvents(i).
Table 6. Aldol reaction of 15 and 16 catalysed by 0.2 equivalents of 19a in differing solvents(i).
EntrySolventConversion
(%)
syn:antisyn eeAnti ee
1DMF9357:435279
2THF9945:555576
3EtOH9252:484686
4MeOH7152:484875
(i) General conditions Catalyst (0.2 equiv.), 15 (1.0 equiv.), 16 (10 equiv.), solvent (0.33 M relative to 15), rt.
Table 7. Aldol reaction of 15 and 16 catalysed by 26 (i).
Table 7. Aldol reaction of 15 and 16 catalysed by 26 (i).
EntryTimeConversion
(%)
syn:antisyn eeAnti ee
143664:36326
284063:372214
3107161:392214
(i) General conditions Catalyst 26 (0.2 equiv.), 15 (1.0 equiv.), 16 (10 equiv.), DMF (0.33 M relative to 15), rt.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Al-Taie, Z.S.; Coles, S.J.; Congreve, A.; Ford, D.; Green, L.; Horton, P.N.; Jones, L.F.; Kett, P.; Kraehenbuehl, R.; Murphy, P.J.; et al. C2-Symmetric Amino Acid Amide-Derived Organocatalysts. Reactions 2024, 5, 567-586. https://doi.org/10.3390/reactions5030027

AMA Style

Al-Taie ZS, Coles SJ, Congreve A, Ford D, Green L, Horton PN, Jones LF, Kett P, Kraehenbuehl R, Murphy PJ, et al. C2-Symmetric Amino Acid Amide-Derived Organocatalysts. Reactions. 2024; 5(3):567-586. https://doi.org/10.3390/reactions5030027

Chicago/Turabian Style

Al-Taie, Zahraa S., Simon J. Coles, Aileen Congreve, Dylan Ford, Lucy Green, Peter N. Horton, Leigh F. Jones, Pippa Kett, Rolf Kraehenbuehl, Patrick J. Murphy, and et al. 2024. "C2-Symmetric Amino Acid Amide-Derived Organocatalysts" Reactions 5, no. 3: 567-586. https://doi.org/10.3390/reactions5030027

Article Metrics

Back to TopTop